Transcription of Methicillin-resistant Staphylococcus aureus (MRSA) Protocol
{{id}} {{{paragraph}}}
Methicillin-resistant Staphylococcus aureus (MRSA) Protocol Approved by Provincial IPC Surveillance Committee: June 2010 Revised: April 2022 Approved: June 2010 Revised: April 2022 AHS/Covenant Health - Provincial Surveillance Protocol (MRSA) Page | 2 Copyright 2022 Alberta Health Services. This material is protected by Canadian and other international copyright laws. All rights reserved. This material may not be copied, published, distributed or reproduced in any way in whole or in part without the express written permission of Alberta Health Services (please contact the Senior Provincial Director of Infection Prevention and Control at This material is intended for general information only and is provided on an "as is", "where is" basis. Although reasonable efforts were made to confirm the accuracy of the information, Alberta Health Services does not make any representation or warranty, express, implied or statutory, as to the accuracy, reliability, completeness, applicability or fitness for a particular purpose of such information.)
• For MRSA-BSI, the case classification for the BSI and for the MRSA are determined independently. • Classify the MRSA based on the MRSA protocol and the BSI based on the BSI protocol. • Note: Each new MRSA BSI episode must be entered in ProvSurv but not every positive blood culture result from the same BSI episode.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
MRSA, Centers for Disease Control and, Methicillin-resistant Staphylococcus Aureus, Based, Change in Isolation Practice for MRSA and, Evidence-Based Best Practices – Infection Control, Septic shock: Guideline-based management, MRSA risk assessment and monitoring, Methicillin-resistant . Staphylococcus aureus